Zimmer biomet holdings inc

美股醫療保健

ZBH 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面獲得最高評分,股利評分不錯,值得長期累積部位。若想獲得較好的進場時機,可參考技術面趨勢與波段評分

ZBH 近期報酬表現

1.13%

Zimmer biomet holdings inc

1.95%

同產業平均

0.87%

S&P500

與 ZBH 同產業的標的表現

  • SYK Stryker corporation
    價值 3 分趨勢 3 分波段 1 分籌碼 3 分股利 4 分
    查看更多

ZBH 公司資訊

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.

ZBH 股價